IN2015KN00416A - - Google Patents
Info
- Publication number
- IN2015KN00416A IN2015KN00416A IN416KON2015A IN2015KN00416A IN 2015KN00416 A IN2015KN00416 A IN 2015KN00416A IN 416KON2015 A IN416KON2015 A IN 416KON2015A IN 2015KN00416 A IN2015KN00416 A IN 2015KN00416A
- Authority
- IN
- India
- Prior art keywords
- pfs47
- mosquito
- gambiae
- falciparum
- parasites
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261684333P | 2012-08-17 | 2012-08-17 | |
PCT/US2013/055372 WO2014028852A1 (fr) | 2012-08-17 | 2013-08-16 | Utilisation de p47 de plasmodium falciparum (pfs47) ou de plasmodium vivax (pvs47) comme vaccin ou cibles de criblage de médicaments pour l'inhibition de la transmission de la malaria humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015KN00416A true IN2015KN00416A (fr) | 2015-07-17 |
Family
ID=50101528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN416KON2015 IN2015KN00416A (fr) | 2012-08-17 | 2013-08-16 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20150203547A1 (fr) |
EP (1) | EP2885410A4 (fr) |
CN (1) | CN104736710A (fr) |
BR (1) | BR112015003184A2 (fr) |
IN (1) | IN2015KN00416A (fr) |
WO (1) | WO2014028852A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018157083A1 (fr) | 2017-02-24 | 2018-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions et méthodes pour bloquer la transmission du plasmodium |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002077195A2 (fr) * | 2001-03-26 | 2002-10-03 | Walter Reed Army Institute Of Research | Proteine ama-1 de plasmodium falciparum et ses applications |
CN102264381B (zh) * | 2008-10-01 | 2014-07-09 | 美国政府(由卫生和人类服务部的部长所代表) | 提供对疟原虫的长效免疫应答的用于疟疾的多组分疫苗 |
DK2763694T3 (en) * | 2011-10-04 | 2018-04-16 | Statens Seruminstitut | Preparation of a cysteine-rich protein |
-
2013
- 2013-08-16 US US14/421,964 patent/US20150203547A1/en not_active Abandoned
- 2013-08-16 IN IN416KON2015 patent/IN2015KN00416A/en unknown
- 2013-08-16 EP EP13830027.2A patent/EP2885410A4/fr not_active Withdrawn
- 2013-08-16 WO PCT/US2013/055372 patent/WO2014028852A1/fr active Application Filing
- 2013-08-16 CN CN201380054025.3A patent/CN104736710A/zh active Pending
- 2013-08-16 BR BR112015003184A patent/BR112015003184A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR112015003184A2 (pt) | 2018-05-08 |
CN104736710A (zh) | 2015-06-24 |
WO2014028852A1 (fr) | 2014-02-20 |
US20150203547A1 (en) | 2015-07-23 |
EP2885410A1 (fr) | 2015-06-24 |
EP2885410A4 (fr) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023014569A (es) | Anticuerpos anti-sirpa. | |
MD3718565T2 (ro) | Vaccinuri împotriva virusului respirator | |
EP3408392A4 (fr) | Éradication du virus jc humain et d'autres polyomavirus guidée par un arn | |
MX2014004814A (es) | Compuestos y metodos para mejorar las respuestas inmunes innatas. | |
WO2018193063A3 (fr) | Nouveaux vaccins contre le paludisme et anticorps se liant aux sporozoïtes de plasmodium | |
IN2014CN04187A (fr) | ||
WO2016210384A3 (fr) | Bactéries manipulées pour traiter des maladies métaboliques | |
WO2017066706A8 (fr) | Souches recombinées vaccinales de listeria et leurs méthodes d'utilisation en immunothérapie anticancéreuse | |
WO2015052543A3 (fr) | Vaccination antipaludique | |
EA201790507A1 (ru) | Способы и композиции для усиления иммунных ответов | |
PH12014501388A1 (en) | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv | |
EA201300132A1 (ru) | Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич | |
WO2015123493A3 (fr) | Compositions et méthodes de modulation de réponse immunitaire | |
WO2015054678A3 (fr) | Vaccin thérapeutique contre le papillomavirus humain | |
MX2022002635A (es) | Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso. | |
TW201613977A (en) | Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use | |
GEP20197052B (en) | Hyr1-derived compositions and methods of treatment using same | |
PH12015502844A1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
WO2014140166A3 (fr) | Vaccin | |
WO2013108272A3 (fr) | Vaccin antipaludique ciblant le stade sanguin | |
NZ606563A (en) | Bacterial ghosts for mediating innate immunity | |
IN2014DN09445A (fr) | ||
IN2015KN00416A (fr) | ||
GB201112587D0 (en) | Vaccine | |
PH12018500201A1 (en) | Enhanced immune response in porcine species |